Key result
Novel bioabsorbable stent combines EPC capture with sirolimus elution to promote vascular repair.
Answers are grounded in this paper and cite their sources.
The field of stent based tissue engineering continues to revolutionise modern medicine by designing novel materials to restore vascular tissue function. Accordingly, the following discussion examines a novel, absorbable, polymeric scaffold engineered in combination with dual therapeutic coating, enabling locally administered temporary scaffolding in the coronary arteries for long term vascular patency and repair. This coronary stent platform consists of an absorbable polymeric material stent structure that incorporates a dual partitioned coating, by means of pro-healing EPC (endothelial progenitor cell) capture technology allowing for rapid endothelial coverage, and an absorbable polymer matrix with sustained elution of sirolimus, a drug controlling neointimal proliferation. This paper provides a brief overview of the various innovations developed by OrbusNeich to create this fully absorbable coronary device platform.
No takes yet. Share an insight, caveat, or question.
Cottone et al. (2009) conducted a review in Coronary artery disease. OrbusNeich fully absorbable coronary stent platform with dual partitioned coatings (EPC capture technology and sirolimus) was evaluated. The OrbusNeich fully absorbable polymeric coronary stent platform combines endothelial progenitor cell capture and sustained sirolimus elution for vascular patency and repair (no clinical data).
Synapse has enriched 10 related papers. Consider them for comparative context: